Small Company Champion & Lemming Investors Research and Newsletter Updates

Sunday, 11 April 2021

Open Orphan - Launch of Disease in Motion platform Launch



Open Orphan Plc (ORPH), a rapidly growing speciality pharmaceutical services clinical research organisation (CRO) and world leader in vaccine and antiviral testing using human challenge clinical trials, announces that hVIVO, a subsidiary of Open Orphan, has officially launched its Disease in Motion® platform. This unique data-focused platform includes clinical, immunological, virological and digital (wearable) biomarkers. The Disease in Motion platform has multiple infectious disease applications that apply to a wide variety of end-users, including big tech, wearables, pharma and biotech companies.


Ramsdens Holdings - Dissapointing Trading Due to Covid-19


Ramsdens Holdings Plc (RFX) the diversified financial services provider and retailer, announces a pre-close trading update for the six months ended 31 March 2021. Announced it has been affected negatively by fewer transactions from its lucrative jewellery retail trading and foreign currency, thus the company expects a "small loss" for its first half, due to Covid-19 restrictions.

It did flag these as likely issues. However, the focus was always on post-Covid-19 and therefore the smart money would be accumulating ahead of normality because the company is in a solid position with no financial issues concerning its survival.